Specialties

Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?

There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis. 

Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?

A VERTIS CV sub study showed significant improvements in glycemic control after adding ertugliflozin to insulin-based regimens.

Diabetes is the leading cause of chronic kidney disease due to microvascular damage to the renal blood vessels.

A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children. 

Individuals with mental health disorders have an increased risk for type 2 diabetes and premature death; modifiable risk factors affected by antipsychotics are obesity, insulin resistance, diabetes, and dyslipidemia.

Finerenone is a mineralocorticoid receptor antagonist indicated for chronic kidney disease (CKD) with type 2 diabetes. Does the use of insulin affect its performance against kidney and cardiovascular issues?

Researchers investigate the changes in ambulatory blood pressure using the antidiabetic drug in patients with type 2 diabetes and hypertension.

A meta-analysis was conducted to determine the impact of physical activity on cognition improvement in patients with diabetes.